SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-291076
Filing Date
2022-11-22
Accepted
2022-11-22 16:09:03
Documents
15
Period of Report
2022-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d376367d8k.htm   iXBRL 8-K 28049
2 EX-1.1 d376367dex11.htm EX-1.1 194610
3 EX-5.1 d376367dex51.htm EX-5.1 8449
7 GRAPHIC g376367g1121072550934.jpg GRAPHIC 2308
  Complete submission text file 0001193125-22-291076.txt   409380

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rapt-20221117.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20221117_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20221117_pre.xml EX-101.PRE 11254
9 EXTRACTED XBRL INSTANCE DOCUMENT d376367d8k_htm.xml XML 3355
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 221410410
SIC: 2834 Pharmaceutical Preparations